A Giant Retroperitoneal Dedifferentiated Liposarcoma: A Case Report and Comprehensive Review of Multidisciplinary Management
Keywords:
Retroperitoneal Sarcoma, Dedifferentiated Liposarcoma, Surgical Oncology, En Bloc Resection, Multidisciplinary Management, STRASS TrialAbstract
Introduction : Retroperitoneal liposarcoma (RLPS) is a rare mesenchymal malignancy characterized by large tumor size at diagnosis and a high propensity for local recurrence. Giant RLPS, particularly the high-grade dedifferentiated subtype, presents formidable diagnostic and therapeutic challenges. Case Illustration : We present the case of a 64-year-old male with a one-year history of progressive abdominal distension. Physical examination revealed a massive, firm abdominal mass. Contrast-enhanced computed tomography (CT) identified a 35 x 25 x 20 cm heterogeneous retroperitoneal mass with both fatty and large non-lipomatous components, consistent with dedifferentiated liposarcoma. The patient underwent an exploratory laparotomy with a successful en bloc compartmental resection, which included the tumor, the right kidney, the right adrenal gland, and a segment of the ascending colon. The resected specimen weighed 10.4 kg. Histopathology confirmed a grade 3 dedifferentiated liposarcoma arising from a well-differentiated liposarcoma, with negative surgical margins (R0). The patient had an uneventful postoperative recovery and is undergoing surveillance. Discussion : This case highlights the central role of radical surgical resection as the only potentially curative modality for primary RLPS. The discussion provides a comprehensive review of the diagnostic utility of cross-sectional imaging, the principles of compartmental surgery to achieve negative margins, and the current, evolving landscape of adjuvant therapies. We critically analyze the results of the landmark EORTC-STRASS trial, which failed to show an overall benefit for preoperative radiotherapy but suggested a potential benefit in the liposarcoma subgroup, creating an ongoing clinical controversy. The limited role of systemic therapy outside of the advanced or metastatic setting is also reviewed. Conclusion : The management of giant RLPS is complex and necessitates a multidisciplinary approach at a specialized sarcoma center. Complete surgical resection remains the cornerstone of treatment, while the role of neoadjuvant therapies continues to be refined through histology-specific clinical trials.References
Al-Sinaidi, A., Al-Bahri, M., Al-Sukaiti, R., Al-Musafir, T. and Al-Busaidi, S. (2025) 'A case report of the largest retroperitoneal dedifferentiated liposarcoma', Frontiers in Oncology, 15, p. 1489833.
Al-Zoubi, M. and Al-Rawashdeh, A. (2024) 'Surgical management of giant retroperitoneal liposarcoma: Case report', ResearchGate.
Anaya, D.A., Lev-Chelouche, D., Farcas, A., et al. (2021) 'Update in pelvic and retroperitoneal sarcoma', Cirugía Española (English Edition), 99(3), pp. 183-191.
Ben Aissia, A., Boujelben, S., Ghorbel, I., et al. (2025) 'Giant retroperitoneal liposarcoma: a case report', Journal of Surgical Case Reports, 2025(2), p. rjaf056.
Bonvalot, S., Gronchi, A., Le Péchoux, C., et al. (2020) 'Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial', The Lancet Oncology, 21(10), pp. 1366-1377.
Cardona, K. (2024) Trial Spotlight: Ken Cardona Gives an Update on the EA7211 (STRASS 2) Sarcoma Trial. ECOG-ACRIN Cancer Research Group Blog.
City of Hope (n.d.) Retroperitoneal Sarcoma Treatments.
Crago, A.M. and Brennan, M.F. (2015) 'Systemic therapy for advanced liposarcoma: a review of recent clinical trial results', Current Opinion in Oncology, 27(4), pp. 338-344.
Demetri, G.D., von Mehren, M., Jones, R.L., et al. (2016) 'Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial', Journal of Clinical Oncology, 34(8), pp. 786-793.
Dickson, M.A., Schwartz, G.K., Keohan, M.L., et al. (2013) 'Progression-free survival and objective response rate of eribulin mesylate in patients with soft-tissue sarcoma by histologic subtype: results from a phase 2, open-label, multicenter study', Cancer, 119(17), pp. 3299-3306.
ESMO, EURACAN, and GENTURIS (2021) Management of Soft-Tissue and Visceral Sarcomas Clinical Practice Guidelines. Medscape.
Gronchi, A., Miah, A.B., Dei Tos, A.P., et al. (2021) 'Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up', Annals of Oncology, 32(11), pp. 1348-1365.
Gronchi, A., Strauss, D.C., and Miceli, R. (2022) 'Prospective, multi-institutional, international cohort study of patients with retroperitoneal liposarcoma (RPLS) to determine the impact of total retroperitoneal lipectomy (TRL) on oncologic outcomes', Annals of Translational Medicine, 10(12), p. 696.
Haas, R.L.M., Bonvalot, S., Miceli, R., et al. (2023) 'Radiotherapy for primary retroperitoneal sarcoma: a phase 3, randomised, controlled trial, an off-trial cohort, and a pooled analysis', The Lancet Oncology, 24(10), pp. 1148-1159.
Hassan, I., Park, J.S., and Donohue, J.H. (2005) 'Operative management of primary retroperitoneal sarcomas: a reappraisal of an institutional experience', Annals of Surgery, 241(6), pp. 934-940.
Italiano, A., Toulmonde, M., Cioffi, A., et al. (2016) 'Advanced soft tissue sarcomas: A retrospective study of 208 patients treated with first-line curative-intent chemotherapy', Cancer, 122(10), pp. 1565-1573.
Jeong, W., Kim, J.H., and Cho, H.J. (2021) 'Multiple large well-differentiated liposarcomas with different patterns of appearance on computed tomography image can occur simultaneously in the same patient: A case report', World Journal of Gastrointestinal Surgery, 13(26), pp. 108308.
Jones, R.L., Fisher, C., Al-Muderis, O., et al. (2017) 'Differential sensitivity of liposarcoma subtypes to chemotherapy', European Journal of Cancer, 84, pp. 129-137.
Keung, E.Z. and Pollock, R.E. (2020) 'A contemporary review of retroperitoneal liposarcoma', Chinese Clinical Oncology, 9(4), p. 53.
Lee, J.C., Thomas, J.M., Phillips, S., et al. (2011) 'Aggressive surgical strategy for primary retroperitoneal sarcoma: a 10-year experience at a tertiary referral centre', Annals of Surgical Oncology, 18(3), pp. 732-739.
Lewis, J.J., Leung, D., Woodruff, J.M., et al. (1997) 'Prognostic factors associated with long-term survival for retroperitoneal sarcoma: implications for management', Journal of Clinical Oncology, 15(8), pp. 2832-2839.
Livingston, J.A., Bugano, D., Messersmith, H., et al. (2020) 'Systemic therapy for liposarcoma: a review', Translational Gastroenterology and Hepatology, 5, p. 55.
MacNeill, A.J. and Gronchi, A. (2021) 'The 2021 management of retroperitoneal soft-tissue sarcoma', Current Oncology, 28(5), pp. 3438-3449.
Mussi, C., Colombo, P., Bertuzzi, A., et al. (2015) 'Retroperitoneal sarcoma: a review of the literature', Frontiers in Surgery, 2, p. 4.
NCCN (2025) NCCN Guidelines for Patients: Soft Tissue Sarcoma. National Comprehensive Cancer Network.
Nishino, M., Hayakawa, K., Minami, M., et al. (2003) 'Primary retroperitoneal neoplasms: CT and MR imaging findings with anatomic and pathologic diagnostic clues', Radiographics, 23(1), pp. 45-57.
Nussbaum, D.P., Rushing, C.N., Lane, W.O., et al. (2021) 'Preoperative radiotherapy for retroperitoneal sarcoma: Where do we go from here?', Bulletin of the American College of Surgeons, 106(2), pp. 25-33.
O'Sullivan, B., Davis, A.M., Turcotte, R., et al. (2002) 'Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial', The Lancet, 359(9325), pp. 2235-2241.
Park, J.O., Qin, L.X., Prete, F.P., et al. (2017) 'Predicting outcome by growth rate of locally recurrent retroperitoneal liposarcoma: the "6-month rule"', Annals of Surgery, 265(1), pp. 186-192.
Porpiglia, M., Fiori, E., Lirici, M.M., et al. (2015) 'Giant retroperitoneal liposarcoma: a case report and review of the literature', Case Reports in Surgery, 2015, p. 929234.
Radiopaedia (n.d.) Retroperitoneal liposarcoma.
Radsource (2024) Lipoma and Liposarcoma. Web Clinics.
Sanfilippo, R., Blay, J.Y., and Duffaud, F. (2021) 'Systemic therapy in advanced liposarcoma', Future Oncology, 17(1), pp. 83-96.
Sbaraglia, M., Bellan, E., and Dei Tos, A.P. (2021) 'The 2020 WHO classification of soft tissue tumours: news and perspectives', Pathologica, 113(2), pp. 70-84.
Schöffski, P., Chawla, S., Maki, R.G., et al. (2016) 'Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial', The Lancet, 387(10028), pp. 1629-1637.
Singer, S., Demetri, G.D., Baldini, E.H., et al. (2015) 'Management of soft-tissue sarcomas: an overview and update', The Lancet Oncology, 16(1), pp. e82-e93.
Stavrou, M., Grivas, A., and Michail, O. (2016) 'Surgical management of retroperitoneal sarcomas: a single-center experience', Journal of BUON, 21(2), pp. 415-420.
Stoeckle, E., Coindre, J.M., Bonvalot, S., et al. (2004) 'Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group', Cancer, 100(11), pp. 2490-2496.
Tan, M.C., Brennan, M.F., Kuk, D., et al. (2008) 'Histology-based classification predicts survival in patients with retroperitoneal sarcoma', Annals of Surgery, 247(4), pp. 580-586.
The WHO Classification of Tumours Online (2020) Soft Tissue and Bone Tumours. 5th edn. International Agency for Research on Cancer.
Tseng, W.W.L., Amini, A., and Canter, R.J. (2023) 'Surgical management of primary retroperitoneal sarcoma', Surgical Oncology Clinics of North America, 32(3), pp. 521-537.
Tseng, W.W.L., Tsao-Wei, D.D., Callegaro, D., et al. (2018) 'Pan-Asian retroperitoneal sarcoma working group (PARS) study: A multi-institutional collaborative analysis of clinical features and outcomes of 1055 patients with primary retroperitoneal sarcoma', Journal of Surgical Oncology, 118(1), pp. 132-140.
WHO Classification of Tumours Editorial Board (2020) Soft tissue and bone tumours. 5th edn. Lyon: International Agency for Research on Cancer.
Xu, C., Ma, Z., Zhang, H., et al. (2016) 'Prognostic factors predicting the postoperative survival period following treatment for primary retroperitoneal liposarcoma', Chinese Journal of Cancer Research, 28(1), pp. 101-109.
Zagar, T.M., Tsvang, L., and Cardona, K. (2021) 'Radiation therapy for retroperitoneal sarcomas: A STRASS-ful situation', Current Oncology, 30(1), p. 47.
Zhang, H., Zhang, Z., and Liu, H. (2021) 'Pathological prognostic factors of retroperitoneal liposarcoma: comprehensive clinicopathological analysis of 124 cases', Annals of Translational Medicine, 9(7), p. 574.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Mohammad Jathy Oktariansyah, Nurudin Syahadat, Fifa Yuniarmi (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors publishing here keep copyright but grant the journal first publication rights, under a Creative Commons Attribution-NonCommercial 4.0 License. They can distribute their work non-exclusively elsewhere with an acknowledgment of its first publication in this journal. Posting the work online before and during submission for earlier and greater citation is encouraged, reflecting Open Access benefits.
